KHALIULLIN, F.A.,
KLEN, E.E.,
PAVLOV, V.N.,
SAMORODOV, A.V.,
SHEPILOVA, S.O.,
MAKAROVA, N.N.,
NURLANOVA, S.N.,
ABZALILOV, T.N. (2022) toxicity,
local irritation)
and acceptable bioavailability (in terms of the topological polar surface area).
Mingazheva, E.T.,
Prokofyeva, D.S.,
Valova, Ya.V.,
Andreeva, E.A.,
Nurgalieva, A.Kh.,
Valiev, R.R.,
Ekomasova, N.V.,
Faishanova, R.R.,
Romanova, A.R.,
Khusnutdinova, E.K. (2022) , differentiation, as well as
immune response and inflammation. Recently, biological microarray technologies have
Dobrodeeva, V.S.,
Shnayder, N.A.,
Novitsky, M.A.,
Asadullin, A.R.,
Vaiman, E.E.,
Petrova, M.M.,
Limankin, O.V.,
Neznanov, N.G.,
Garganeeva, N.P.,
Nasyrova, R.F. (2022) (chromosome
localization—4q32.2). Group 1 comprised 25 patients with SSDs taking APs with a change in body